"CAMC Memorial Hospital is home to one of the highest volume heart programs in the United States. Comprehensive cancer care is also housed on Memorial Hospital's campus. Our multidisciplinary team includes radiation, gynecologic and medical oncologists, as well as oncology pharmacists, psychologists dedicated to the care of cancer patients and their families, case coordinators, social workers and skilled oncology registered nurses. Memorial Hospital also is the site of a comprehensive diabetes center, family medicine and internal medicine clinics, Vascular Center of Excellence and general medical-surgical inpatient services."

During the past decade, Charleston Area Medical Center, General Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charleston Area Medical Center, General Hospital" #1 collaborator was "Edwards Lifesciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Charleston Area Medical Center, General Hospital" are "Analgesia" (2 trials), "Acute Coronary Syndrome" (1 trials), "Angina Pectoris" (1 trials), "Atherosclerosis, Coronary" (1 trials) and "Constipation" (1 trials). Many other conditions were trialed in "Charleston Area Medical Center, General Hospital" in a lesser frequency.

Most popular intervention types in "Charleston Area Medical Center, General Hospital" are "Device" (3 trials), "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cerebral State Monitor" (1 trials), "FloTrac™ and EV1000™" (1 trials), "Ixmyelocel-T" (1 trials), "Naloxone and Docusate" (1 trials) and "Orsiro DES" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charleston Area Medical Center, General Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Charleston Area Medical Center, General Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Charleston Area Medical Center, General Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Charleston Area Medical Center, General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".